Cited by 22Analytical Methods in PharmaceuticalsBiosimilars and Bioanalytical MethodsPesticide Residue Analysis and Safety

SPE–UPLC–MS/MS assay for determination of letrozole in human plasma and its application to bioequivalence study in healthy postmenopausal Indian women

Open access
Vanol, Pravin G., Singhal, Puran, Shah, Priyanka A., Shah, Jaivik V., Shrivastav, Pranav S., Sanyal, Mallika·2016·Journal of Pharmaceutical Analysis

Abstract

A rapid and sensitive ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method is described for determination of letrozole in human plasma. Following solid phase extraction (SPE) of letrozole and letrozole-d4 on Orochem DVB-LP cartridges, chromatography was performed on Acquity UPLC BEH C 18 (50 mm×2.1 mm, 1.7 µm) column using methanol-0.1% formic acid in water (85:15, v/v) as the mobile phase. Detection was carried out on a triple quadrupole mass spectrometer with an electrospray source, operated under positive ionization mode. Quantitation of letrozole and letrozole-d4 was done using multiple reaction monitoring (MRM) following the transitions at m/z 286.2→217.0 and m/z 290.2→221.0, respectively. The calibration plots were linear through the concentration range of 0.10–100 ng/mL ( r 2 ≥0.9990) using 100 µL human plasma. The extraction recovery of letrozole ranged from 94.3% to 96.2% and the intra-batch and inter-batch precision was ≤5.2%. The method was successfully applied to a bioequivalence study of letrozole after oral administration of 2.5 mg tablet formulation to 16 healthy postmenopausal Indian women. The assay reproducibility was also established through incurred sample reanalysis (ISR) of 74 subject samples.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpha.2016.05.004

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LC-MS-MS methods for LTZ in plasma are sensitive and selective with low level of quantification but require trained personnel and sophisticated equipment.

    “The liquid chromatographic method utilizing MS-MS systems has been used for the analysis of LTZ letrozole in plasma, which are sensitive and selective with a low level of quantification. However, such methods require operation by trained personnel and sophisticated equipment (Joshi et al. 2011; AlShehri et al. 2019; Vanol et al. 2016).”

    From A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics (2021) · cites this paper as Vanol et al. 2016

    The Introduction and Conclusion describe LC–MS/MS methods for letrozole in human plasma as sensitive and selective, with low quantification limits; the Experimental section documents the specialized UPLC and mass-spectrometry equipment used. Our copy does not state that these methods require trained personnel. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 10

  1. [1]Bhatnagar A.S. The discovery and mechanism of action of letrozole Breast Cancer Res. Treat. 105 2007 7 17 PMC2001216 17912633
  2. [2]Keating G.M. Letrozole: a review of its use in the treatment of postmenopausal women with hormone-responsive early breast cancer Drugs 69 2009 1681 1705 19678717
  3. [6]Filipe A. Almeida S. Spinola A.C.F. Bioequivalence study of two letrozole tablet formulations. Single dose, randomized, open-label, two-way crossover bioequivalence study of letrozole 2.5 mg tablets in healthy volunteers under fasting conditions Arzneim. Forsch. 58 2008 419 422 18807583
  4. [10]Shao R. Yu L.Y. Lou H.G. Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring Biomed. Chromatogr. 30 2016 632 637 26317321
  5. [12]Acharjya S.K. Bhattamisra S.K. Muddana B.R.E. Development of a high-performance liquid chromatographic method for determination of letrozole in wistar rat serum and its application in pharmacokinetic studies Sci. Pharm. 80 2012 941 953 23264941 PMC3528055
  6. [13]Precht J.C. Ganchev B. Heinkele G. Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS Anal. Bioanal. Chem. 403 2012 301 308 22367241
  7. [14]Rodríguez J. Castaneda G. Munoz L. Rapid determination of letrozole, citalopram and their metabolites by high performance liquid chromatography-fluorescence detection in urine: Method validation and application to real samples J. Chromatogr. B 913–914 2013 12 18 23262245
  8. [15]Beer B. Schubert B. Oberguggenberger A. Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study Anal. Bioanal. Chem. 398 2010 1791 1800 20730580
  9. [17]Shah P.A. Sharma P. Shah J.V. An improved LC–MS/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5-hydroxy pyrazinoic acid inhuman plasma for a pharmacokinetic study J. Chromatogr. B 1017 2016 52 61 26945134
  10. [19]Yadav M. Shrivastav P.S. Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research Bioanalysis 3 2011 1007 1024 21545349

Cited by

Sorted by citations

Authors
Vanol, P. G., Singhal, P., Shah, P. A., Shah, J. V., Shrivastav, P. S., & Sanyal, M.
Affiliations
  • St Xavier’s College (IN)
  • Alkem (India) (IN)
  • Gujarat University (IN)
Corresponding author
Sanyal, Mallika
Venue
Journal of Pharmaceutical Analysis
Publisher
Elsevier BV
Published
2016-08
Volume
6
Issue
4
Pages
276-281
ISSN
2095-1779 (ISSN-L)
OpenAlex
W2397876743
Cited by
22
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 1 · 2018: 2 · 2017: 1
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Pharmaceutical Analysis (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Department of Chemistry, St. Xavier's College, Ahmedabad
Topics
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Pesticide Residue Analysis and Safety
Keywords
letrozole, bioequivalence, human plasma, solid-phase extraction, UPLC-MS/MS, postmenopausal women, oral tablet formulation, pharmaceutical analysis, isotope-labeled internal standards, incurred sample reanalysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review